FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Dorsey Wright & Associates | 4,889 | $22,881 | 0.01% |
| Point72 Asset Management, L.P. | 328,868 | $1,535,814 | 0.01% |
| 1832 Asset Management L.P. | 734,321 | $3,429,279 | 0.00% |
| FMR LLC | 4,681,457 | $21,909,219 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 334,577 | $1,563,570 | 0.00% |
| TWO SIGMA ADVISERS, LP | 65,400 | $305,418 | 0.00% |
| Schonfeld Strategic Advisors LLC | 14,800 | $69,116 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 31,154 | $145,489 | 0.00% |
| MORGAN STANLEY | 137,611 | $642,643 | 0.00% |
| BlackRock Inc. | 8,253 | $38,541 | 0.00% |
| UBS Group AG | 93,960 | $438,793 | 0.00% |
| SIGNATUREFD, LLC | 300 | $1,401 | 0.00% |
| Cubist Systematic Strategies, LLC | 100 | $467 | 0.00% |
| SIMPLEX TRADING, LLC | 1,401 | $6 | 0.00% |
| ROYAL BANK OF CANADA | 1,839 | $9,000 | 0.00% |
| TD Waterhouse Canada Inc. | 700 | $3,234 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,325 | $10,858 | 0.00% |
| JPMORGAN CHASE & CO | 2 | $9 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,374 | $142,150 | 0.00% |
External links
This page lists FUSION PHARMACEUTICALS INC's shareholders in Q2 2023. To view FUSION PHARMACEUTICALS INC's shareholder history, click here.